Show simple item record

dc.contributor.authorWilliams, CA
dc.contributor.authorBarker, AR
dc.contributor.authorDenford, S
dc.contributor.authorvan Beurden, SB
dc.contributor.authorBianchim, MS
dc.contributor.authorCaterini, JE
dc.contributor.authorCox, NS
dc.contributor.authorMackintosh, KA
dc.contributor.authorMcNarry, MA
dc.contributor.authorRand, S
dc.contributor.authorSchneiderman, JE
dc.contributor.authorWells, GD
dc.contributor.authorAnderson, P
dc.contributor.authorBeever, D
dc.contributor.authorBeverley, Z
dc.contributor.authorBuckley, R
dc.contributor.authorButton, B
dc.contributor.authorCauser, AJ
dc.contributor.authorCurran, M
dc.contributor.authorDwyer, TJ
dc.contributor.authorGordon, W
dc.contributor.authorGruet, M
dc.contributor.authorHarris, RA
dc.contributor.authorHatziagorou, E
dc.contributor.authorErik Hulzebos, HJ
dc.contributor.authorKampouras, A
dc.contributor.authorMorrison, L
dc.contributor.authorCámara, MN
dc.contributor.authorReilly, CM
dc.contributor.authorSawyer, A
dc.contributor.authorSaynor, ZL
dc.contributor.authorShelley, J
dc.contributor.authorSpencer, G
dc.contributor.authorStanford, GE
dc.contributor.authorUrquhart, DS
dc.contributor.authorYoung, R
dc.contributor.authorTomlinson, OW
dc.date.accessioned2022-09-15T13:25:21Z
dc.date.issued2022-09-06
dc.date.updated2022-09-15T12:43:02Z
dc.description.abstractBACKGROUND: The roles of physical activity (PA) and exercise within the management of cystic fibrosis (CF) are recognised by their inclusion in numerous standards of care and treatment guidelines. However, information is brief, and both PA and exercise as multi-faceted behaviours require extensive stakeholder input when developing and promoting such guidelines. METHOD: On 30th June and 1st July 2021, 39 stakeholders from 11 countries, including researchers, healthcare professionals and patients participated in a virtual conference to agree an evidence-based and informed expert consensus about PA and exercise for people with CF. This consensus presents the agreement across six themes: (i) patient and system centred outcomes, (ii) health benefits, iii) measurement, (iv) prescription, (v) clinical considerations, and (vi) future directions. The consensus was achieved by a stepwise process, involving: (i) written evidence-based synopses; (ii) peer critique of synopses; (iii) oral presentation to consensus group and peer challenge of revised synopses; and (iv) anonymous voting on final proposed synopses for adoption to the consensus statement. RESULTS: The final consensus document includes 24 statements which surpassed the consensus threshold (>80% agreement) out of 30 proposed statements. CONCLUSION: This consensus can be used to support health promotion by relevant stakeholders for people with CF.en_GB
dc.description.sponsorshipCystic Fibrosis Trusten_GB
dc.format.extent14799731221121670-
dc.identifier.citationVol. 19en_GB
dc.identifier.doihttps://doi.org/10.1177/14799731221121670
dc.identifier.grantnumberSRC#008en_GB
dc.identifier.urihttp://hdl.handle.net/10871/130851
dc.identifierORCID: 0000-0002-1740-6248 (Williams, Craig A)
dc.identifierScopusID: 57201609242 (Williams, Craig A)
dc.identifierResearcherID: AAQ-8954-2020 (Williams, Craig A)
dc.identifierORCID: 0000-0003-4063-7682 (Tomlinson, Owen W)
dc.language.isoenen_GB
dc.publisherSAGE Publicationsen_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/36068015en_GB
dc.rights© The Author(s) 2022. Open access. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).en_GB
dc.subjectclinical practiceen_GB
dc.subjecthealthen_GB
dc.subjectlifestyleen_GB
dc.subjectrespiratory diseaseen_GB
dc.titleThe Exeter Activity Unlimited statement on physical activity and exercise for cystic fibrosis: methodology and results of an international, multidisciplinary, evidence-driven expert consensusen_GB
dc.typeArticleen_GB
dc.date.available2022-09-15T13:25:21Z
dc.identifier.issn1479-9723
exeter.place-of-publicationEngland
dc.descriptionThis is the final version. Available on open access from SAGE Publications via the DOI in this recorden_GB
dc.descriptionData availability statement: All results are presented within the manuscript and supplementary files.en_GB
dc.identifier.eissn1479-9731
dc.identifier.journalChronic Respiratory Diseaseen_GB
dc.relation.ispartofChron Respir Dis, 19
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/en_GB
dcterms.dateAccepted2022
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2022-09-06
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2022-09-15T13:22:50Z
refterms.versionFCDVoR
refterms.dateFOA2022-09-15T13:25:36Z
refterms.panelAen_GB
refterms.dateFirstOnline2022-09-06


Files in this item

This item appears in the following Collection(s)

Show simple item record

© The Author(s) 2022. Open access. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Except where otherwise noted, this item's licence is described as © The Author(s) 2022. Open access. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).